Ustar

About Ustar

Ustar Biotechnologies (Hangzhou) Ltd. is a biotechnology company specializing in point-of-care testing (POCT) molecular diagnostics. Founded in 2005 by Qimin You, the company is dedicated to the research, development, manufacturing, and sales of rapid nucleic acid diagnostic technologies.

The company's business model revolves around providing comprehensive solutions for instant molecular diagnostics, serving nearly 3,000 medical institutions across more than 70 countries. Ustar develops and sells proprietary technologies and products, including instrument-free nucleic acid extraction devices, isothermal amplification testing kits, and rapid DNA amplicon detection devices. Its product lineup features systems like EasyNAT®, PortNAT®, and MultNAT®, which are designed for on-site diagnosis of infectious diseases, genetic mutations, and more without requiring a traditional laboratory setup. These systems are based on the company's patented Cross Priming Amplification (CPA) and reagent vitrification technologies, which allow for rapid, stable, and cost-effective testing.

Ustar has actively participated in national projects for infectious disease control and has received certifications from the National Medical Products Administration (NMPA) for its analyzers and COVID-19 test kits. The company has secured significant funding, including a Series E round, from investors such as the Gates Foundation and Legend Capital, to support its work in developing diagnostics for major diseases like tuberculosis and COVID-19.